Oral valproic acid vs placeboChange in quality of life · ambulatory adults with SMA type III1 finding from 1 reviewDrug treatment for spinal muscular atrophy types II and III 2020 · Cochrane Headline outcomes onlyno estimate extracted28 participantsModerate
Oral valproic acid plus acetyl‐L‐carnitine vs placeboChange in quality of life · non‐ambulatory children with SMA types II and III1 finding from 1 reviewDrug treatment for spinal muscular atrophy types II and III 2020 · Cochrane Headline outcomes onlyno estimate extracted1 study · 54 participantsVery low